Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia
NCT06743854 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2024-12-27
Summary
The goal of this observational study is to detect risk factors for liver affection in patients with chronic hemolytic anemias presented to the hematology unit.
Conditions
- Hemolytic Anemia, Chronic
- Liver Diseases
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mohammed Abbas Al masry, Pro · Assiut University
Eligibility
- Min Age
- 1 Month
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-31
- Primary Completion
- 2025-10-31
- Completion
- 2025-11-30
More Related Trials
-
Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
NCT03405402 ·Status: COMPLETED ·Phase: NA
-
Transferrin Saturation and Asthenia in Hemochromatosis
NCT03356548 ·Status: COMPLETED
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Laboratory Characteristics of Polycythemia Vera
NCT06134102 ·Status: COMPLETED
-
Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)
NCT05303506 ·Status: UNKNOWN
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
Acute Porphyria Biomarkers for Disease Activity
NCT02935400 ·Status: ACTIVE_NOT_RECRUITING
-
Gall Bladder Status Among Children With Chronic Haemolytic Anemia
NCT03533322 ·Status: UNKNOWN
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment
NCT04814394 ·Status: NOT_YET_RECRUITING
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
NCT00171171 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
NCT04119050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox
NCT03358498 ·Status: UNKNOWN
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Cystatin c and Beta 2 Microglobulin in Thalassemic Children.
NCT03881917 ·Status: UNKNOWN
-
Long Term Effects of Erythrocyte Lysis
NCT00842621 ·Status: COMPLETED
-
Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective Cohort
NCT07131878 ·Status: NOT_YET_RECRUITING
-
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
NCT05853458 ·Status: TERMINATED ·Phase: PHASE4
-
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833 ·Status: COMPLETED
-
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
NCT01984554 ·Status: COMPLETED
-
Kidney Function in Sickle Cell Anemia
NCT03277547 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
NCT00564941 ·Status: COMPLETED ·Phase: PHASE4